CA1261991A - Method of producing biodegradable prosthesis and products therefrom - Google Patents

Method of producing biodegradable prosthesis and products therefrom

Info

Publication number
CA1261991A
CA1261991A CA000469900A CA469900A CA1261991A CA 1261991 A CA1261991 A CA 1261991A CA 000469900 A CA000469900 A CA 000469900A CA 469900 A CA469900 A CA 469900A CA 1261991 A CA1261991 A CA 1261991A
Authority
CA
Canada
Prior art keywords
poly
lactide
fibers
polymer
biodegradable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000469900A
Other languages
French (fr)
Inventor
Richard L. Dunn
Robert A. Casper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southern Research Institute
Original Assignee
Southern Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southern Research Institute filed Critical Southern Research Institute
Application granted granted Critical
Publication of CA1261991A publication Critical patent/CA1261991A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K7/00Use of ingredients characterised by shape
    • C08K7/02Fibres or whiskers
    • C08K7/04Fibres or whiskers inorganic
    • C08K7/08Oxygen-containing compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body

Abstract

ABSTRACT OF THE DISCLOSURE
Method of producing biodegradable prostheses comprising a composite of resorbable fibers reinforcing a biodegradable polymer matrix and the use thereof in medical applications such as bone plates and other orthopedic devices. The fibers include ceramic powders, .beta.-TCP and CaAl and a biodegradable glass, CMP.

Description

.
l~
BACKGROUND O~ THE INVENTION
The need for improved methods and materials to manage severe maxillofacial injuries is well recognized, In such cases, ~be surgeon faces the dual problem o~ restoring ~unction and appearance. The patient su~erlng ~rom an extenslve ma~illo~acial in~ury is typically confronted with dis~igurement, impaired speech, and eating di~iculties as well as the psychological trauma resulting ~rom the injury.
Ideally, ~ixation applicances should maintain the ~ractured bone se~ments in close approximation ior the promotion oi primary union Qnd heal1ng~ provide su~icient strength and rigidity to prevent disruption o~ the primary union by external ~orces, and as the union becomes ~urther osslfied, trans~er an ~ncreasing proportion oi the external load to the healing bone so that it wlll be strained and exercised. The iulPillment o~ these crlteria is necessary i'or the Yormation o~ healthy, hard tissue that has properties commensurate with those o~ virgin bone.
Implant materials used ~or such in~uries over the years belong to three traditional classes: metals, c~ramics, and polymere. The choice of material ior the particular application depends on the type and magnltude of applied loads which the lmplant is expected to experience in vivo and whether the implant ~is to be a permanent or a temporary augmentation. When trying to make repairs to the skeletal system, surgeons and engineers must ~tlemp~ to replicate the static and dynamic responBes o~ bone.

` ~ ~
~.,., I , :~

-Bone consists of a ~ramework of collagenous fibers, a m1neral matri~ consisting primarily o~ calcium hydroxyapatite, and a small amount of polysaccharides. Although bone is stronger and less deformable than polymeric materials, it is weaker than metals.
Historically, metals have received wide application for the construction of devices for fixing fractures. Metals exhibit high values of tensile strength and compressive modulus; they can be fabricated into flxation hardware by a variety of conventional techniques; and they provide excellent resistance to the in vivo environment. Met~ls and alloys now used as surglcal implants include 31~ stainless steel, several cobalt-chromlum alloys, titanium, zirconium alloys and tantalum.
In mandlbular i'racture repair, one o~ the major disadvantages with metal implants is atrophy oi' ~he healing bone as a result of the stress-protectlcn eP~ect o~ the rigid metal plate. Other drawbacks with metal fi~ation appliances are that they may cause local ln~lamation and maY corrode with age.
Among the metallic materials, tantalum is superior in resistance to corrosion and has been extensively employed as i'ixation plates i'or ~ractured bones and as implants. The metal is, however, difficult to process. In contrast, ceramic materlal6 show good affinity to bones often with bone tissue penetrating into the fine pores of the ceramic to produce a strong ~i~ation.
Bone and tissue compatibility with ceramics is e~cellent. The main disadvantage of ceramic materials is their poor impact strength as they are oi'~en brittle. This conditlon is quite evident with the more porous ceramic~ and leads to poor durabili~y o~ ceramic implant6 and fixation devices. On the other hand, polymeric materials provide excellent impact strength, good biocompatibillty, and they are easlly molded to the desired shape;

¦however, they do not possess the requlred strength and stifPnes6 ~¦~or bone fi~ation.
,~ Those materials and many o~ the prior art materials ¦Isufi'er from the common drawback of being permanent. In many ;lapplications, such as a fixation appliance holding ~ fracture together while it heals, it is highly desirable if the implant can be resorbed by the body. Such an implant would biodegrade over Q
period of weeks or years, and be gradually replaced by natural bone growth. Such materials eliminate the need for a second surgery to remove the implant. However, homogenous fixation plates previously fabricated ~rom biodegradable polymers have been shown to possess 1nsu~icient strength and rigidlty i'or lnitial iracture fixation. Porous resorbable ce~amics have also been used in bone repair, but they must be used in con~unction with other support because o~ their fragile nature.
The prior art includes U.S. Patent No. 3,929,971 which discloses a synthetic material (either hydroxapatite or whitlockite) that may ~e used with other materlals, such as organic polymers, to iorm a composite substance which could be use~ul in constructing a degradable prosthetic implan~; U.S0 Patent No. 3,905,047 which discloses a blodegradable prosthesis containing an eutectic or metal pyrophosphate and high-modulus ~ibers ~ormed o~ a reYractory metal oxide; U.S. Patent 4,330,514 is directed to a process ior preparing a hydroxyapatite ceramic which is used in a nondegradable implant comprising the ceramic and an organic bindin~ ma~erial; and U.S. Patent 4,356,572 which is directed to a porous biodegradable bone implant which utilizes calcium carbonate ln crystalline ~orm.

, ~, ..

?~:~

SUMMAHY ()F Tl~ lNV~N'r~N

~ he disadvantages of -the prior art are overcome by the present invention comprising biodegradable, high-strength, rigid fixation systems formed of composites of biodegradable polymers reinforced with resorbable fibers, particularly calcium phosphate fibers; the degradation products of the composites of the present invention are nontoxic and harmless to the host. The preferred polymers include polyglycolide (~GA), poly(~L-lactide) (~L-PLA), poly(DL-lactide-co-glycolide) (DL-PLG), poly(L-lactide) (L-PLA), poly(L-lactide-c~-glycolide) (L-PLG), polycaprolactone (~CL), polydioxanone, polyesteramides, copolyoxalates and the polycarbonates because of t~eir degradation times and their degree of control of degradation.
'rhe relnforcing fibers include the ceramic or the preferred glass forms of calcium phosphate. The ceramic fibers include those comprising R-tricalcium phosphate. These fibers may be prepared by wet-spinning mixtures of the powders with different polymeric binders, such as polyacrylonitrite (PAN-A), and solvents, such as dimethyl suifoxide (~MS~). Ceramic loading, oxidative pretreatment, coupling agents and sintering conditions affect spinnability and fiber properties. ~`ibers of phosphate-free calcium aluminate (CaAl) produced by the same process may also be used although the resulting fibers are fragile and may fracture easily.
Due to the highly porous and fragile nature of the fibers produced from the ceramic powders, the preferred fibers of the present invention are glass fibers. Smooth, uniform fibers of calcium metaphosphate ~Ca(PO3)2](CMP), a bioabsorbable glass, may be prepared by extruding or pulling filaments from a melt and air quenching. ~ibers can also be prepared by the same process from a partially bioabsorbable glass compbsed of a mi~ture of silicon dioxide, sodium oxide, calcium oxide and phosphorous pentoxide.
It is preferred to use continuous filament fibers so that a high ratio of length to cross sectional area is ob-tained, the length to diameter or aspect ratio ranging from 10:1 to 1,000,000:1.
The invention in one broad aspect pertains to a method of producing a biodegradable prosthesis, comprising the steps of encasing an effective amount of resorbable fibers 10 selected from the group consisting of calcium phosphate and calcium aluminate in a matrix ofa biodegràdable synthetic polymer to form a composite, the effective amount ranging from 10 - 90% by volume and the aspect ratio of said fibers ranging from 10:1 to 1,000,000:1, and forming the composite to the desired prosthetic shape.
Another aspect of the invention pertains to a method of producing a biodegradable fracture-fixation appliance reinforcement, comprising the steps of preparing resorbable calcium phosphate fibers having an aspect ratio of 10:1 to 20 1,000,000:1, incorporating from 10 - 90~ by volume of the fibers within a nontoxic biodegradable polymer to form a composite, and fabricating the reinforcement from the composite.
Another aspect of the invention comprehends a bio-degradable prosthesis, comprising a biodegradable polymer matrix and fibers selected from the group-consisting of calcium phosphate and calclum aluminate incorporated within the matrix in an amount ranging from 10 - 90% by volume and the fibers having an aspect ratio of 10:1 to 1,000,000:1.
Still further, the invention comprehends a method of 30 producing a totally biodegradable composite material for :~ pros~hetic and implant devices, comprising the step of encasing an effective amount of a reinforcing material in the form of fibers selected from the group consisting of calcium :: ~
:.

,:,, d ~ !~ u phosphate and calcium aluminate in a matrix of a polymer selected from the group consisting of polyglycolide, poly(DL-lactide) r poly(L-lactide), polycaprolactone, polydioxanone, polyesteramides, copolyoxalates, polycarbonate, poly(glutamic-co-leucine) and blends, copolymers and terpolymers thereof.
Yet another aspect of the invention pertains to a totally biodegradable composite material for prosthetic and implant devices, comprising from 10 - 90% by volume of a reinforcing material in the form of fibers selected from the group consisting of calcium phosphate and calcium aluminate, and a polymer encasing the reinforcing material, the polymer being selected from the group consisting of polyglycolide, poly~DL-lactide), poly(L-lactide), poly-caprolactone, polydioxanone, polyesteramides, copolyoxalates, polycarbonate, poly~ylutamic-co-leucine) and blends, copolymers and terpolymers thereof.

- 7a -'~: J
. ,.

~ 7~

D~TAIL~ UE~CRIPTI~N OF TH~ ILI.USTRATIV~ M~OI)IMLNT

The present invention relates to the incorporation ofhigh-strength, high-modulus, biodegradable fibers in biodegradable' polymers to form totally absorbable fracture-fixation plates or devices. The use of two bioabsorbable ceramic powders, ~-TCP and CaAl, and a bioabsorbable glass, CMP, is described.

A. Preparation of Ceramic Materials -~ one contains a matrix of calcium hydro~yapatite, a resorbable ceramic material, in callagen. The calcium hydroxyapatite provides rigidity and the same material, when incorporated into biodegradable polymers, should provide the necessary reinforcement for use as fixation plates or devices. A
variety of` ceramic forms of hydroxyapatite [CalO(~4)~(~H)~l and tricalcium phosphate [CA3(P04)~l have been reported in the literature. Recent evidence indicates that ceramic forms of hydroxyapatite ar~ inert as implant materials while those of tricalcium phosphate (Whitlockite) are bioabsorbable. The strength, durabllity, and absorption kinetics of tricalcium phosphate ceramics depend on the phasic nature of tbe final product, the lattice structure of the phases present, and the porosity and total surface area.
Preparation of a calcium phosphate ceramic of high purity and single-phase nature is accomplished by the precipitation method of Salsbury and Doremus for pro~uction of ~-Whitlockite (~-TCP), as follows:
A solution of calcium nitrate (1.40 moles) in 900 mL of distilled water is brought to pH 11 to 1~ with concentrated .. . . . .. ... .. . .. ...

ammonium hydroxide and thereafter diluted to 1~00 mL. A solution of ammonium phosphate (1.00 moles) in 150n mL distilled water is brought to pH 11 to 12 with concentrated ammonium hydroxide and thereafter diluted to 3~00 mL to dissolve the resulting precipitate. The pH is again checked and additional concentrated ammonium hydroxide is added if necessary.
The calcium solution is vigorously stirred at room temperature, and the phosphate solution is added ln drops over 30 to 40 minutes to produce a milky, somewhat gelatinous precipitate which is then stirred overnight (more than 1~ hours). The reaction mixture is then centrifuged, and the clear supernatant fluid decante~. The resulting mineral sludge is homogeneously resuspended in distilled water to serve as a feedstock.
To produce green states which should afford lOU%
~-Whitlockite ceramics, aliquots of the feedstock are recentrifuged, homogeneously suspended in two volumes of dilute a~ueous ammonium sulfate (1 to 2%) and then filtered on a Buchner funnel with application o~ mild suction and a rubber dam. After filtration for several hours, the compact clay-like cake is drie~
intact at 9~C for 15 hours to prodllce directly the green state.
~intering conditions, of course, may vary with the material and the phase or phases desired in the final productO
For the production o~ ~-Whitlockite, the green cake may be placed on an alumina dish and initially heated to 60UC over 0.5 hours.
The temperature is then raised quickly to 1150C, the cake is slntered isothermally at llS0C for 1 hour, the temperatllre is reduced to 900C, and the ceramic is cured at 900C for 4 hours.
Calcium aluminate is another resorbable ceramic material. Calcium aluminate of a 50:5U Ca/Al wt % composition [CaAl204] (CaAl) was 6U% resorbed after one year implantation in monkeys, The Ca/Al rntio can he varied to produce several ,,,, , . . ....... .. _ ¦~combinat~ons of crystallographic phases and the various phases ~hydrolyze at varying rates providing a method ~or controlling the l¦rate of ceramic dissolution. CaAl can be purchased ~rom Pialtz &
¦¦~auer, Inc~, Stamford, CT consisting o~ CaA1204 with quantities o~ Al203 and Cal2All4022 as impurities.

. Preparation of Fine-Particle Sized Ceramic Powder ~ o prepare rei~orclng ceramic iibers, especially with small diameters, it is necessary that the ceramic material con6i~t of small particlee. The s~all part1cles allow the estru~lon Or small-diameter ceramic ilament~, and the finer particle 6ize results in greater densliicatlon on sintering. Greater den~iiication and t~e ~ssoclated reduction ln void volume oi ~ormed articles produces ceramic products, whether ln pellet, rod or ~iber ~orm, with greater 6trength and structural rigidity. In addition, the bre~kinB strength oi sintered cer~mlc ~ibers ~6 usually inversely proportional to the diameter o~ the ~lber; thus, the smaller the ~lber, the stronger lt i~ per unit ~ize. The sa~e relationship has been iound with ~lntered TCP ~ibers.
One method to reduce the ceramic powder to small 20 particles is the use o~ a Megapack high-energy vibrAtory mill.
The system employs the u~e o~ ~mall-diameter steel balls vlbratlng at high ~requencles ~or grlnding o~ ceramic powders. The procedure u~ed to grind ceramlc ~amples to ~lne partlcle ~izes wi:th thls mlll is a6 ~ollows: A slurry oi TCP (or phocphate-~ree C~Al) ln WQter ~as added to the vibratory mill, and the mlll ~a6 activRted and allowed to run ~or 4 hour~. During that tlme, ~ample~ were take~ a~ periodia intervals and e~amined by scanning electron microscopy ~SEM) to determine particle-slze range. A
m111ing time o~ 4 hOUr6 W~6 ~ound to be sui~i~lent to yteld ~ particles in the l- t~ 2-~m range. At the end o~ that time, the *trademark ~ ~1 slurry was removed from the mill and centrifuged for 30 minutes at 100 g. The supernatant was decanted and dimethyl acetamide was added to the centrifuge bottle; the contents were then agitated to resuspend the compacted ceramic powder. This process was repeated several times until all of the water was replaced by dimethyl acetamide.
The vibratory milling technique allowed preparation of slurries of ceramic powder in the appropriate polymer solvent both effect~vely and ef~iciently. Ceramic particles in this size ranKe were appropriate ~or use in the wet-spinning o~ ~ine diameter iilaments.

C. Wet-~pinnin~ of_C_ramic Fibers Usi_g Polymeric Binders Of the number o~ methods for use in the production o~
ceramic fibers e~amined, i'iber production by wet-spinning appears to be the most success~ul method, Sim~listically fipeaking, ~iber production by wet-spinning involves extruding a mlxture o~ cera~ic powder, binder (PAN-A), and solvent (DMSO) into a trough or bath contalning a non-solvent ~or the binder. During extruslon into the non-solvent bath, the mixture coagulates to ~orm a ~iber or ~ilament. For s~1ccess fn making fibers by wet spinning, the solvent ~or the binder must be soluble in the coagulating bath, which must be ~ non~solvent for the binder.
The fibers or ~ilaments are subsequently drawn from the coagulating bath using a series oi water-~lushed, heated godets to rinse and evaporate the remaining solvent. A~ter passing through the rlnsing and drying system, the ~bers are taken up on a winding reel. The collected ~ibers are then soaked in dlstilled water to assure complete solvent removal and are, therea~ter, drled in an alr-circulating oven to produce the final dried i'lber.
For the production o~ fibers ~rom both ~-TCP and phosphate-~ree ' ' '':

~CaAl, it is necessary to sinter the dried fibers ln an inert atmosphere (nitrogen) maintained above 1150C to achieve coalesence and densification of the ceramic particles.
l. Polymeric Blnders As a consequence of the elevated temperature required for proper sintering of both~-TCP and phosphate-~ree CnAl, polymeric binders with superior thermal stability are required for use in the wet-spinning process. Although no resin yet produced is capable of withstanding these temperatures, three highly thermally stable resins ~ere examinéd to see i~ they mlght effectively bind the ceramic powders together in ~iber form until preliminary sinterlng (lower temperature) was achieved. These binders were Bare~ 210 (Vistron Corp., Chemicals Dlvision, Cleveland, OH), a terpolymer mostly composed o~ acrylonitrile;
Polyacrylonitrile Type A (PAN-A) (Du Pont, Wllmlngtsnl DE); and Ethocel ~1 Standard (Dow Chemical Co., Mldland, UI), an ethylcellulose material.
The thermal stability o~ PAN-A and, hence, the spun fiber, may be enhanced by subJecting the material to an o~idative pretreatment. The pretreatment lmproves thermal stability by forming a ladder polymer. Ethyl cellulose o~ered s~mllar thermal stability without the necessity o~ a pretreatment step, although the fibers prepared ~ith ethyl celluloæe are lnierior to tho~e ~ith PAN-A as a binder.
2. Dlspersin~ agents In wet spinning o~ ceramic ~ibers, dispersing agents are o~ten used to prevent clumping o~ the ceramic particles and plugging o~ the in-llne ~ilter screen. Nuosper~e, obtalned Yrom Tenneco Chemlcals (Plscat~way, NJ) is more compatlble wlth the spinnlng solvent, D~SO, than Tamol 9~0 and Tamol SN fro~ Rohm and Haas tPhiladelphia, PA). It was successi'ul in preventlng clumping * Trademarks ~ .,, ¦¦of the ceramic particles, and its addition to the spinning dope ¦improved the spinnability of the ceramic mater~als.
3. ~TCP fibers TCP powder ~repared as described previously was wet sieved using No. 6~ (250-~m) and No. 140 (160-~m) sieves. The fine particle cut was used to make the spinning dope. TCP was mixed with a solution of PAN-A in DMS0 to make up the spinnlng composition~ Care was taken to remove any entrapped air bubbles.
The final spinning dope consisted of 7.4% TCP, 1.8~ PAM-A, and 90.8% DMS0 on a weight basis.
Fibers were prepared by wet extrusion using a hypodermic syrlnge and hypodermic needles of varlous sizes. The needles ranged from 15 G (1~37 mm ID) to 27 G (002 mm ID). Distilled water at room temperature was used as the coagulating medium. The spinning dope was loaded into the syringe barrel, and the tip o~
the needle was placed below the surface o~ the coagulating fluid.
Pressure was applied until a bead of coagulum formed at the needle's tip. The bead was grasped with a pair of tweezers and pressure was reapplied to the syringe barrel. Fibers were extruded ~or the length o~ the coagulating bath. Fibers prepared using the smaller diameter needles were considerably more difficult to extrude than ~lbers prepared uslng the larger ~eedles. The extruded fibers were removed irom the coagulatln8 bath and placed iD another water bath and allowed to soak to remove solvent. After soaking for a su~ficlent time, the fibers were removed from the bath with tweezers and placed on Teflon sheeting to dry in air overnight. The smaller fibers were easier to handle and exhibited more struc~ural integrity. This was probably due to a higher resldual solvent content in the larger ~lbers.

B -TCP fibers were also prepared on wet~spinning equipment designed ~or production o~ rayon fibers. A spinning dope consisting of 10% R-Tcp~ 15% ~arex 210 ~crylic polymer, and 75~ N,N-dimethylacetamide was loaded into a cylindrical, stainless steel iee(i pot. The feed po~ was pressurized with compressed air ~0 psi), and the spinning dope was $orced from the feed pot through stainless steel tubing (0.25-in.-0~, type 304) to a Zenith gear pump driven by a Zenith Model QM drive motor. The Zenith pump delivered the spinning dope (at 0.~ cm~ per revolution;
1.45 cm3/min) to a spinneret with an orarice diameter o~ 0.020 in. The spinneret was submerged in a water bath. As the spinnin~
dope came in contact with the water, it coagulated to form a fiber. After traversing the coagul~tion bath (1~ in.), the ~iber was taken up by the fir~t godet. This godet (80 ~t/min sur~ace speed; 107F) was equlpped with a tap water spray to remove solvent ~rom the ~iber. The iiber was then taken up on a second heated gode~ ~84 ~t/min suriace speed; 97F) and rinsed with a warm water spray. The iiber was passed around a third heated godet (87 ft/min sur~ace speed; 105F) and collected on a Leesona Model 955 take-up winder.
The fibers were then sub~ected to oxidatiYe pretreatment to promote the formation Or a ladder polymer and enhance the thermal stability of the binder matrix. Pretreatment was accomplished by placing the fibers in an air-circulatlng oven maintained at 200C for 3~ minutes. Pyrex test tubes were used to contain ~he fibers during the pretreatment process. The ~ibers changed from white to tan during pretreatment.
After pretrea~ment, the ~ibers were sintered in a Lindberg ~levi-Duty SB oven* The oven was malntained a~ 1~00C and~
purged with nitrogen for the duration of the sintering cycle. The *Trademark .' 1 1~7~
sintered ~ibers were light yellcw. A~ter sinterlng, soma of the ~ibers shrank to less than 40% oi their original diameter.
The ~lbers were tested gor breaking strength on an Instron*Model TUS Serlal 72 testing machine. The ~ibers were prep~red ~or testing by mounting on cardboard tnbs. The ~inest fibers were attached to the t&bs wlth p~ra~in, aDd the larger fibers were attached with sealing wax. Samples were pulled at a rate of 1 in./min. until ~racture occurred and the ~orce at break was determined. After being tested, the samples ~ere removed ~rom the Instron, the dlameter at the $racture point was determined with a micrometer and used to calculate the brea~ing strengtb in terms of ~orce per unit area. The ~racture suriacea were the~
e~amined by SEM. The test results are presented in the iollo~ing table:

B~EAKING STRENG~H OF TRICALCIU~ PHOSPHATE FIBERS
. , _ . .
Average diameter Breaklng strength mm _ psi 0.508 353 0.~5~ 6~
0.124 419 0.122 477 0.074 1607 There is a dramatic e~ect o~ ~lber diameter on tensile strength. As ~iber dlameter decreases, the Rtrength incre~ses.
Such behavior is commonly ~ound in the preparation o~ ceramic Sibers. Results shown in the table reflect the average o~ test results ~or ~lve specimens o~ each ~ibsr diameter. One sample o~
~ the smallest diameter fiber had a tensile strength o~ 2500 psl.
SE~ photos showed voids and irregularities at the ~racture sur~ace of all specimens. In general, larger voids were asaociated wlth lo~er breaking strength, reilecting the streS~-cODCentrating effect~ o~ the irregularities.
trademark ~ 15 -; ~, .'r.. '' "'~ ~ `.
4. CaAl fibers Fibers of phosphate-free calcium aluminate were prepared following the procedures used for ~-TCP ~iber production and usin~
the same solvent and binder. A~ter sintering, the fibers were quite fragile.
Calcium aluminate (Pfaltz & 13auer, Inc., Stamford, CT) was used to prepare the fibers. X-ray diffraction analysis revealed that the powder consisted of CaAl~O~ but also contained significant amounts of Al2()~ and Cal2Al1~l0~. 'rhe CaAl ~as dry sieved through a No. 100 sieve (150-~m) to break up any clumps and remove any large particles.
! The spinning dope had a ceramic-to-binder ratio of ~0:2() and consisted by weight of 25% CaAl, ~% ~AN-A, and 6~% UMSO.
Fibers were extruded from a hypodermic syringe and needle, as were the TCP fibers. Needle siz~es 15 G through 25 G were used to form fibers, The 27 G needle proved to be too fine for the CaAl dope.
The fibers were coagulated in a tap-water bath at ambient temperatures. The coagulated fibers were quite rigid and easier to handle ~han the TC~ ~ibers at this stage. CaAl fihers were also prepared by the pilot-scale equi~ment used for the ~-TC~
fiber production. A 70:30 by wt blend of CaA1 and Barex 210 in a suspension in N,N-dimethylacetamide was extruded at a rate of 1.75 cm3/min into tap water at 70~F. The ~irst and second godets were operating at a speed of 94 ftJmin and the third godet at a speed of 96 ft/min. The temperatures were 110, 115, and 115F for the three godets respectively. The fibers were dried at ambient conditions overnlght. Oxidative pretreatment was performed in a circulating-air oven at 200C for 30 minutes. ~rior to oxidation the fibers were white. Aft~r oxidation the fibers turned brown.
The fihers were then placed in an oven under a nitrogen purge, heated at 1200C, held for 1 ho~lr, .

: ::

l . ~
and allowed to cool overn~ght. When the fiber~ were removed ~rom the oven, they wers ~ound to be e~tremely ~ragile.
¦D. Fiber Production ~rom Blod~ radable Glas6es Although sintering oi ceramic particles produces bioabsorbable ceramic ~ibers, the volds still preeent ln the ~ibers c~use them to be somewh~t ~ragile and ~eak. A void-~ree ceramic ~iber produced by melt~ng and extrusion o~ a bloabsorbable glass gives a stronger and more durable ~iber ~or u~e ln polymer reinforcement. Gla~ses are converted to ilbers by drawlng ~iber~
~rom hot melts. The high ~ur~ace tension and 810w r~te o~ change oi' viscosity wlth temperature o~ melted glass permit6 ~ormation oi stable meniscuses and enables ~ibers to be ~ormed and drawn irom a suitable crucible aYter the natural ~lo~ o~ molten glass downward by gravity. Both marble melt and direct melt proceæses are used to produce gla88 ~ibers.
1. ~io~l~ss ~ibers Bioglass i8 a partially biodegr&dabl~ gla66 composed o~
~5% silicon dlo~ide, and various metallic o~ideR (sodium o~ide, calcium oxide and pho~phorous pe~toxide). Only the sllicon dioxide portion of the glass is non-absorbable.
Fibers ~ere prepared from the Bioglas~ by heating the material in a crucible until it beca~e molten (900 C) a~d ~ithdrawing Yilaments wlth a stainless steel rod. Fibers ~ere produced by thls procedure, but there was considerable varlation in both ~iber dlameter ~rom sample to s~mple and unirorm~ty o~
dlameter throughout the length o~ a given ~ampl~. Samples o~ the glass ~ibers were mounted and tested ln the same manner as the ceramic iibers. Breaking strength oi the gla~s iibers varied ~rom 9000 to 50,000 psi~ This variation ~as to be expected in view oi the lack of uni~ormity from one sample to the ne~t. However, the iormation o~ iibers ~ith hlgh ten~ile strength~ was evident.

*trademark Fibers prepared in the fashion described above were tested for bioabsorption. Samples of the fibers were cut into 2-in~ lengths for breaking strength detemination, and the 2-in.
lengths were weighed, Some fibers were mounted and broken to determine initial breaking strength. Their average initial breaking strength was about 45,000 psi, and their average diameter was ~.026 mm. The remaining fibers were placed in phosphate-buffered saline a~ a pH of 7.2 in a 37 C oven for 18 ! days, The fibers were then removed Yrom the saline, dried, I reweighed, and broken to determine final breaking strength, Their ;, average wei~ht loss was about 5%, and their average breaking strength was less then 200 psi.
2. ~MP fibers CMP is known as a hydrolytically unstahle glass, Consisting of calcium and phosphorous, it degrades within the body to harmless components of normal body fluid. CMP, however, must be properly purifled before it can be spun into fibers for use in reinforcin~ biodegradable polymers~ F'ollowing the procedure g1ven in U.~. Patent No, 4,~)4~,779, CMP of sufricient purity ~or fiber formation is obtained. One liter of a 3-molar solution of phosphoric acid was prepared. One hundred grams of CaCo3 was then slowly dissolved in the acid solution. Impurities were removed by precipitating with 2,5 g of ammonium 1-pyrrolidine dithiocarbamate dissolved in 50 mL of water. The resulting grey precipitate was then removed by filtration. The supernatant was concentrated by evaporation, and the pure CMP was precipitated.
The precipitate was ~iltered and washed with acetone to remove any residual phosplloric acid. Th~ whit~ material was then placed in ~ an alumina dish and baked in an oven at 600C ~or 24 hours, 800C

for 7~ hours, and cool~ slowly to room temperature. l`he baking ' ' : '. :

i steps allow the CMP salt to be chemically condensed and i polymerized to produce the CMP glass.
The resulting grey, foamed, brick-llke substance is then placed in an alumin~ or platinum crucible, heated in an oven at 600~C for 2 hours, at 800C ~or 16 hours, and at 1000C for 2 hours, after which time the crucible is removed from the oven and trans~erred to the ~iber drawing apparatus. This equipment consists of an oxygen/natural gas heating source ~or the crucible and a 3.75 in, -OD stainless steel take-up spool ~or drawing the ~ibers, The speed o~ the spool can be controlled to produce flbers with the desired diameters. A typical draw speed of 7.2 in./sec. is used. The spool is also heated with a natural gas ~lame. By insertlng the tip o~ a stainless steel rod into the molten glass, a ~iber c~n be drawn from the melt and passed around the take-up spool. IP the melt is maintained at the proper temperature (~1000C), a very fine glass ~iber can be wound on the take-up spool. The resulting ~ibers have good strength and uniformity. A typical ~iber has a tensile ~trength oi approximately 51,0~0-110,000 psi, an initial modulus o~ 5 x 106psi, a diameter of about 5 mils, and ~ density o~ 2,67 g/cm3. These properties are comparable to commercial glass flbers.
In vitro studies o~ the CMP ~ibers in 0.9% U~P sallne at 37C show the fiber begins to dissolve irom the surface after only lO days, and they are completely dlssolved a~ter 30 day6.

D. Biode~radable COmDOSiteS
For the hlgh-strength, high-modulus, bioabsorbable ceramic or glass flbers to be useful, they must be incorporated lnto a biodegradable polymer matrix. The matrix protects the flbers from abrasion and breakage, and they provide a structure 3~
I for bone-fixation plates. The fibers in return provide the structural rigidity needed for the polymer plate or device to maintain support.

1. Biodegradahle Polymers The following polymers (with their approximate degradation times) are all candidates for the biodegradable composite of the present inventlon~ These polymers are all biodegradable to water-soluble, nontoxic materials which can be eliminated from the body. All are well known for use in humans and ~heir safety has been demonstrated and approved by the FDA.
Although these polymers are normally linear, crosslinked reslns can be prepared from these materials by those skilled in the art, and these materials are also included as suitable biodegrudable polymer matrices.

Polymer Polycaprolactone 24-36 Poly(L-lactide) 24 Poly(DL-lactide) 12-18 Polyglycolide 3-4 95:5 Poly(~L-lactide-co-glycolide) 12 9O:lO Poly(DL-lactide~co-glycolide) 10 85:15 Poly(DL-lactlde-co-glycolide) 9 75:25 Poly(DL-lactide-co-glycolide) S
50:50 Poly(DL-lactide-co-glycolide) 2 9O:10 Poly~DL-lactlde-co-caprolactone) 9 75:25 Poly(DL-lactlde-co-caprolactone) 6 50:50 Poly(~L-lactlde-co-caprolactone) 2 Polydioxanone 12 Polyesteramides 4-12 Copolyoxalates 4-12 Polycarbonates 2-12 Polg(glutamic-co-leucine) 2~-48 The pre~erred polymers are the poly(DL~lactide-co-glycolide) materials because of the degradation times and their degree of control of degradation. The poly(L-lactide-co-glycolide) materlals not mentioned ln the table should give similar results. Poly(DL-lactide) is also pre~erred as are the polydioxanone, polyesteramides, copolyoxalates and ~he polycarbonates, Polycaprolactone, poly(L-lactide), and the l poly(glutamic-co-leucine) are less preferred because of their long ¦¦degradation times.
With a composite formed from a biodegradable polymer and resorbable fibers, the strength decreases with resorptlon time within the body. This decrease in strength is important because the ~ixation plate trans~ers the load with time to the healing bone and prevents stress protection atrophy. The loss o~ strength of the polymer plates rein~orced with biodegradable ~ibers will depend primarily upon the degradation rate of the polymer because the polymer completely encases the fibers. The degradation rate o~ the polymeric matrix depends upon the type o~ polymer used. It should be noted th~t the degradation times set iorth above are ~or complete disappearance from the polymer. The time ~or s~rength loss in the composite will be considerably less and can be approximated as one hal~ the total polymer degradation tlme.
Composltes which lose their strength in one month will be use~ul as well as those that last up to about one year. ~he preferred tlmes will be three to six mon~hs. It should also be noted that the biodegradation times of the polymers and the correspondlng ~trength losses of the composites will depend upon polymer molecular weights. The values given in the table are ~or normal molecular weights. Higher molecular weight polymers will last longer and those lower in molecular weight will degrade ~aster.
The degradation rate o~ the polymer can be changed by control o~
molecular weight, by the type of biodegradable polymer, and by controlllng the ratio of lactide to glycolide in co-polymers.

2. Reinforcin~ Flbers The term "~iber" as used herein is deflned as any l material that has a high ratio o~ length to cross sectional area ¦ with minimums suggested as 10:1 to 100:1, and a maximum cross sectional area o~ 7085 x 10-5 in.2 and a maximum transverse dimension of 0.010 in. ~ith continuous iilament fibers which are preferred, the length to diameter (a~pect ratio) is maximized to give the best rein~orcement. However, the composites can be made with chopped or shorter lengths o~ ~ibers. With these, the aspect ratio is lower and the level o~ reiniorcement is less. Thus, the aspect ratio can range ~rom 10:1 up to really high numbers such as 1,000,000:1. The pre~erred range is 10~:1 to 1,000,000:1.

3. Composite_Fabrication The Pibers can be incorporated lnto the polymer matrices by several method6. In one approach, the ~ibers can be chopped lnto small pieces, mixed with the molten polymer, and formed into the desired shape by injection molding, compression moldlng, or e~trusion. In another procedure, the chopped iibers can be mixed with a solutlon of the polymer and the mi~ture cast into a ~ilm with evaporation o~ the solvent. The ~ilms can then be laminated or molded to the desired shape. The preferred method, ho~ever, 1 to use contlnuous ~ilaments o~ the fiber to provlde maximum s~rength and regldlty. There~ore, the ceramic or gla6s ~ibers are wrapped around a ~ylar- or Teilon-coated ma~dril and dlpped into or spra~ed wlth a ~olution o~ the polymer in a suitable solvent.
The solvent is evaporated, and the dipping or spraylng repeated to obtai~ a composite ~ilm o~ the de~lred thickneæ~. The ~ilm ls then removed from the mandril, and pre~sed under pre~sure and heat to provide ~lat, bubble-iree shéets. These sheets are then lamin~ted wlth other sheets oi,the same compos~tion or with polymer sheets containing no ~ibers to produce the ~ixation plate.
* Trademarks ~ . ,.

, r 11 As an example, films o~ DL~PLA were prepared from purified polymers having inherent viscosities from 0.58 dL/g to 1~27 dL/g measured in chloroform at 30C. Either ceramic or glass fibers are wrapped around a Mylar-coated mandril and sprayed with a solution of the same l)L-I'LA in p-dloxane. After the solvent evaporates, the spraying is then repeated to obtain a composite film of the desired thickness. When the appropriate thickness is obtained, the film is removed from the mandril, cut, and pressed with ~ hydraulic pI'eSS maintained at 70C and 29,000 psi to provide flat, bubble-free sheets. These sheets are then laminated with sheets of the same polymer containing no fibers to produce a plate. ~'ive sheets of fiber-reinforced material are combined with four sheets of polymer.
~ n another procedure, a hot-pressed film of PLA is placed in a mold and the film is brushed with solvent until it is tacky. Then a layer of the CMP fiher is placed lengthwise along the film taking care not to overlap the fibers which causes breakage. Additional solvent is then brushed over the fiber and another polymer film is placed over the fibers to which it readily adheres. The ~op of the new ~ilm is then wetted, more CMP fibers placed onto it, and the process repeated until 6 layers of fiber are laminated between 7 layers of film to give a composite with ; 40% by volume of CM~ fiber. The solvent is allowed to dry completely, and the laminate is heat-pressed at 60C and 20,000 psi for 15 minutes. This gives better lamination of the ~ilms and removes any residual solvent bubbles.
The plates produced hy this procedure were evaluated in three-point bending tests (AST~ D790). Flexural strengths of 6,0()0-10,()0() psi and fl~xural moduli of about 1 x 106 psi were found. 'rhese compare favorably with those values obtained for nonbiodegradable polymer/fiber composites, and they show the iml)rovements over non-reinforced biodegradable polymer plates.

Flexural Flexural Materials ~treng~h, psi Modulus, psi ~one 10,000-20,0~0 l to 3 x 106 ~teel 75,00() 3() x 1()6 ~L-~LA ~,000-4,~00 ().3 x 106 ! ~arbon-reinforced l)L-YLA 20,000-40,00() l to 4 x 1~6 10, C~-reinforced ~L-PLA ~,00~-1(),00~ l x 1 4. ~olvents for ~iodegradable Polymers The following table sets forth what solvent(s) will dissolve the biodegradable polymers useful in the present invention: ;

Polymers Solvent Polycaprolnctone dichloro~ethan0, 90:l~ ~oly(l)L-lactide-co-eaprolactone) chloroform, toluene 75:~5 poly(~l.-lactide-eo-caprolaetone) xylene, p-di~xane, and 50:5() poly(~L-laetide-co-eaprolactone) TI~F.
poly(~L-lactide) ~5:5 poly(DL-laetide-eo-glycolide) ~():10 polY(l)L-lactide-co-glycolide) ~5:15 poly(~L-lactide-co-glycolide)
5~:50 poly(l)L-lactide-eo-glycolide) HFIP
(hexafluoroisopropanol) and ~FASH
(hexafluoroacetone-; sesquihydrate) : polydixanone tetrachloroethane and chloroform ~-polyesterarnides cresol : copolyoxalates chloroform . polycarbonates ketones, esters and : partially chlorinated hydrocarbons poiy(glutamie-co-leueine) benzene .

' _ 24 -... .. .. , .. . ~ . . . . . .
,

Claims (21)

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:
1. A method of producing a biodegradable prosthesis, comprising the steps of a) encasing an effective amount of resorbable fibers selected from the group consisting of calcium phosphate and calcium aluminate in a matrix of a biodegradable synthetic polymer to form a composite, said effective amount ranging from 10 - 90% by volume and the aspect ratio of said fibers ranging from 10:1 to 1,000,000:1; and b) forming said composite to the desired prosthetic shape.
2. A method as defined in Claim 1 wherein said fibers are calcium phosphate fibers and comprised of .beta. -tricalcium phosphate.
3. A method as defined in Claim 1 wherein said fibers are calcium phosphate fibers and comprised of calcium metaphosphate.
4. A method as defined in Claim 1 wherein said effective amount is preferably 30 - 80% by volume.
5. A method as defined in Claim 1 wherein said polymer is selected from the group consisting of poly-caprolactone, poly(L-lactide), poly(L-lactide-co-glycolide), poly(DL-lactide), polyglycolide, 95:5 poly(DL-lactide-coglycolide), 90:10 poly(DL-lactide co-glycolide), 85:15 poly(DL-lactide-co-glycolide), 75:25 poly(DL-lactide-co-glycolide), 50:50 poly(DL-lactide-co-glycolide), 90:10 poly(DL-lactide-co-caprolactone), 75:25 poly(DL-lactide-co-caprolactone), 50:50 poly(DL-laatide-co-caprolactone), polydioxanone, polyesteramides, copolyoxalates, poly-carbonates, and poly(glutamic-co-leucine).
6. A method of producing a biodegradable fracture-fixation appliance reinforcement, comprising the steps of a) preparing resorbable calcium phosphate fibers having an aspect ratio of 10:1 to 1,000,000:1, b) incorporating from 10 - 90% by volume of said fibers within a nontoxic biodegradable polymer to form a composite; and c) fabricating said reinforcement from said composite.
7. A method of producing a biodegradable prosthesis comprising the steps of:
a) preparing a film of a biodegradable, nontoxic polymer comprising dissolving said polymer in a suitable nontoxic solvent, spin casting the dissolved polymer to form said film, and removing said solvent from said film;
b) incorporating an effective amount of resorbable calcium phosphate fibers into said film;
c) repeating steps a) and b) a preselected number of times so as to form a composite having a predetermined number of layers of said film; and d) shaping said composite into said prosthesis.
8. A method as defined in Claim 7 wherein said solvent is selected from the group consisting of p-dioxane, dimethyl sulfoxide, dichloromethane, chloroform, toluene, xylane, THF, acetone, hexafluoroisopropanol, hexafluoroacetone ses-quihydrate, tetrachloroethane, n-cresol, ketones, esters, partially chlorinated hydrocarbons, water and benzene.
9. A biodegradable prosthesis, comprising a) a biodegradable polymer matrix and b) fibers selected from the group consisting of calcium phosphate and calcium aluminate incorporated within said matrix in an amount ranging from 10 - 90% by volume and said fibers having an aspect ratio of 10:1 to 1,000,000:1.
10. A biodegradable prosthesis as defined in Claim 9 wherein said polymer is selected from the group consisting of polycaprolactone, poly(L-lactide), poly(L-lactide-co-glycolide), poly(DL-lactide), polyglycolide, 95:5 poly (DL-lactide-co-glycolide),90:10 poly(DL-lactide-co-glycolide), 85:15 poly(DL-lactide-co-glycolide), 75:25 poly(DL-lactide-co-glycolide), 50:50 poly(DL-lactide-co-glycolide), 90:10 poly(DL-lactide-co-caprolactone), 75:25 poly(DL-lactide-co-caprolactone), 50:50 poly(DL-lactide-co-caprolactone), poly-dioxanone, polyesteramides, copolyoxalates, polycarbonates, and poly(glutamic-co-leucine).
11. A biodegradable prosthesis as defined in Claim 9 or 10 wherein said matrix is a film of said polymer and said prosthesis comprises a predetermined number of alternating layers of said film and said fibers.
12. A method of producing a totally biodegradable prosthesis or implant comprising the steps of a) encasing an effective amount of fibers selected from the group consisting of calcium phosphate and calcium aluminate in a matrix of a polymer selected from the group consisting of polyglycolide, poly(DL-lactide), poly(L-lactide), polycaprolactone, polydioxanone, polyesteramides, copoly-oxalates, polycarbonate, polylglutamic-co-leucine) and blends, copolymers and terpolymers thereof to form a composite; and b) forming said composite to the desired shape.
13. A method as defined in Claim 12 wherein said calcium phosphate fibers are comprised of .beta.-tricalcium phosphate.
14. A method as defined in Claim 12 wherein said calcium phosphate fibers are comprised of calcium metaphosphate.
15. A method as defined in Claim 12 wherein said effective amount ranges from 10 - 90% by volume.
16. A method as defined in Claim 12 wherein said effective amount is preferably 30 - 80% by volume.
17. A method as defined in Claim 12 wherein the aspect ratio of said fibers ranges from 10:1 to 1,000,000:1.
18. A biadegradable prosthesis or implant, comprising (a) a matrix formed from a polymer selected from the group consisting of polyglycolide, poly(DL-lactide), poly(L-lactide), polycaprolactone, polydioxanone, poly-esteramides, copolyoxalates, polycaxbonate, poly(glutamic-co-leucine) and blends, copolymers and terpolymers thereof;
and (b) fibers selected from the group consisting of calcium phosphate and calcium aluminate incorporated within said matrix in an amount ranging from 10 - 90% by volume and said fibers having an aspect ratio of 10:1 to 1,000,000:1.

l9. A biodegradable prosthesis or implant as defined in Claim 18 wherein said matrix is a film of said polymer and said prosthesis or implant comprises a predetermined number of alternating layers of said film and said fibers.
28
20. A method of producing a totally biodegradable composite material for prosthetic and implant devices, comprising the step of encasing an effective amount of a reinforcing material in the form of fibers selected from the group consisting of calcium phosphate and calcium aluminate in a matrix of a polymer selected from the group consisting of polyglycolide, poly(DL-lactide), poly (L-lactide), polycaprolactone, polydioxanone, polyesteramides, copolyoxalates, polycarbonate, poly(glutamic-co-leucine) and blends, copolymers and terpolymers thereof.
21. A totally biodegradable composite material for prosthetic and implant devices, comprising:
(a) from 10 - 90% by volume of a reinforcing material in the form of fibers selected from the group consisting of calcium phosphate and calcium aluminate;
and (b) a polymer encasing said reinforcing material, said polymer being selected from the group consisting of polyglycolide, poly(DL-lactide), poly(L-lactide), polycaprolactone, polydioxanone, polyesteramides, co-polyoxalates, polycarbonate, poly(glutamic-co-leucine) and blends, copolymers and terpolymers thereof.
CA000469900A 1983-12-19 1984-12-12 Method of producing biodegradable prosthesis and products therefrom Expired CA1261991A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/563,191 US4655777A (en) 1983-12-19 1983-12-19 Method of producing biodegradable prosthesis and products therefrom
US06/563,191 1983-12-19

Publications (1)

Publication Number Publication Date
CA1261991A true CA1261991A (en) 1989-09-26

Family

ID=24249481

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000469900A Expired CA1261991A (en) 1983-12-19 1984-12-12 Method of producing biodegradable prosthesis and products therefrom

Country Status (4)

Country Link
US (1) US4655777A (en)
EP (1) EP0146398A3 (en)
JP (1) JPS60153868A (en)
CA (1) CA1261991A (en)

Families Citing this family (286)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3325111A1 (en) * 1983-07-12 1985-01-24 Merck Patent Gmbh, 6100 Darmstadt IMPLANTATION MATERIALS
US4659617A (en) * 1984-09-11 1987-04-21 Toa Nenryo Kogyo Kabushiki Kaisha Fibrous apatite and method for producing the same
JPS61135671A (en) * 1984-12-04 1986-06-23 三菱鉱業セメント株式会社 Implant material
DE3445738A1 (en) * 1984-12-14 1986-06-19 Draenert Klaus IMPLANT FOR BONE REINFORCEMENT AND ANCHORING OF BONE SCREWS, IMPLANTS OR IMPLANT PARTS
US5522894A (en) * 1984-12-14 1996-06-04 Draenert; Klaus Bone replacement material made of absorbable beads
US4604097A (en) * 1985-02-19 1986-08-05 University Of Dayton Bioabsorbable glass fibers for use in the reinforcement of bioabsorbable polymers for bone fixation devices and artificial ligaments
FI75493C (en) * 1985-05-08 1988-07-11 Materials Consultants Oy SJAELVARMERAT ABSORBERBART PURCHASING SYNTHESIS.
EP0227646A1 (en) * 1985-06-14 1987-07-08 Materials Consultants Oy Surgical device for immobilization of bone fracture
FI78238C (en) * 1985-07-09 1989-07-10 Biocon Oy SURGICAL PURPOSE SYNTHESIS.
EP0226061B1 (en) * 1985-12-17 1994-02-16 United States Surgical Corporation High molecular weight bioresorbable polymers and implantation devices thereof
JPS62221358A (en) * 1986-03-20 1987-09-29 東燃株式会社 Bone lack part and gap part filling material
US4781183A (en) * 1986-08-27 1988-11-01 American Cyanamid Company Surgical prosthesis
FI80605C (en) * 1986-11-03 1990-07-10 Biocon Oy Bone surgical biocomposite material
FI81498C (en) * 1987-01-13 1990-11-12 Biocon Oy SURGICAL MATERIAL OCH INSTRUMENT.
US4756307A (en) * 1987-02-09 1988-07-12 Zimmer, Inc. Nail device
US4772287A (en) * 1987-08-20 1988-09-20 Cedar Surgical, Inc. Prosthetic disc and method of implanting
FR2623402B1 (en) * 1987-11-19 1994-04-29 Solvay ARTICLE OF LACTIC ACID POLYMER FOR USE IN PARTICULAR AS A BIODEGRADABLE PROSTHESIS AND METHOD FOR THE PRODUCTION THEREOF
US5772661A (en) * 1988-06-13 1998-06-30 Michelson; Gary Karlin Methods and instrumentation for the surgical correction of human thoracic and lumbar spinal disease from the antero-lateral aspect of the spine
US7491205B1 (en) * 1988-06-13 2009-02-17 Warsaw Orthopedic, Inc. Instrumentation for the surgical correction of human thoracic and lumbar spinal disease from the lateral aspect of the spine
US5484437A (en) 1988-06-13 1996-01-16 Michelson; Gary K. Apparatus and method of inserting spinal implants
US6120502A (en) 1988-06-13 2000-09-19 Michelson; Gary Karlin Apparatus and method for the delivery of electrical current for interbody spinal arthrodesis
US7534254B1 (en) 1988-06-13 2009-05-19 Warsaw Orthopedic, Inc. Threaded frusto-conical interbody spinal fusion implants
US6210412B1 (en) 1988-06-13 2001-04-03 Gary Karlin Michelson Method for inserting frusto-conical interbody spinal fusion implants
US7431722B1 (en) * 1995-02-27 2008-10-07 Warsaw Orthopedic, Inc. Apparatus including a guard member having a passage with a non-circular cross section for providing protected access to the spine
US6923810B1 (en) * 1988-06-13 2005-08-02 Gary Karlin Michelson Frusto-conical interbody spinal fusion implants
US6770074B2 (en) 1988-06-13 2004-08-03 Gary Karlin Michelson Apparatus for use in inserting spinal implants
US5015247A (en) * 1988-06-13 1991-05-14 Michelson Gary K Threaded spinal implant
US7452359B1 (en) 1988-06-13 2008-11-18 Warsaw Orthopedic, Inc. Apparatus for inserting spinal implants
US6123705A (en) 1988-06-13 2000-09-26 Sdgi Holdings, Inc. Interbody spinal fusion implants
AU7139994A (en) 1988-06-13 1995-01-03 Karlin Technology, Inc. Apparatus and method of inserting spinal implants
US5609635A (en) 1988-06-28 1997-03-11 Michelson; Gary K. Lordotic interbody spinal fusion implants
FI84137C (en) * 1988-07-05 1991-10-25 Biocon Oy BIODEGRADERBAR OCH / ELLER LOESLIG POLYMERMEMBRAN.
AU624627B2 (en) * 1988-08-18 1992-06-18 Johnson & Johnson Orthopaedics, Inc. Functional and biocompatible intervertebral disc spacer containing elastomeric material of varying hardness
US5545229A (en) * 1988-08-18 1996-08-13 University Of Medicine And Dentistry Of Nj Functional and biocompatible intervertebral disc spacer containing elastomeric material of varying hardness
US5634946A (en) * 1988-08-24 1997-06-03 Focal, Inc. Polymeric endoluminal paving process
AU4191989A (en) * 1988-08-24 1990-03-23 Marvin J. Slepian Biodegradable polymeric endoluminal sealing
DE3831657A1 (en) * 1988-09-17 1990-03-22 Boehringer Ingelheim Kg DEVICE FOR THE OSTEOSYNTHESIS AND METHOD FOR THE PRODUCTION THEREOF
US4978358A (en) * 1988-10-06 1990-12-18 Zimmer Inc. Orthopaedic prosthetic device possessing improved composite stem design
JPH02152461A (en) * 1988-12-01 1990-06-12 Nippon Sogo Igaku Kenkyusho:Kk Tissue absorbable film
US5108755A (en) * 1989-04-27 1992-04-28 Sri International Biodegradable composites for internal medical use
US5080665A (en) * 1990-07-06 1992-01-14 American Cyanamid Company Deformable, absorbable surgical device
GB2245559A (en) * 1990-06-25 1992-01-08 Farmos Oy Bioceramic system for delivery of a bioactive compound.
US5462990A (en) * 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
US5626863A (en) * 1992-02-28 1997-05-06 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5410016A (en) * 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
CA2094908C (en) * 1990-12-06 2000-02-08 Byron Kent Hayes Implantable bioabsorbable article
US5320624A (en) * 1991-02-12 1994-06-14 United States Surgical Corporation Blends of glycolide and/or lactide polymers and caprolactone and/or trimethylene carbonate polymers and absorbable surgical devices made therefrom
US6228954B1 (en) 1991-02-12 2001-05-08 United States Surgical Corporation Blends of glycolide and/or lactide polymers and caprolactone and/or trimethylene carbonate polymers and absorabable surgical devices made therefrom
CA2060635A1 (en) * 1991-02-12 1992-08-13 Keith D'alessio Bioabsorbable medical implants
US5480403A (en) * 1991-03-22 1996-01-02 United States Surgical Corporation Suture anchoring device and method
US5354298A (en) * 1991-03-22 1994-10-11 United States Surgical Corporation Suture anchor installation system
US5720753A (en) * 1991-03-22 1998-02-24 United States Surgical Corporation Orthopedic fastener
CA2063159C (en) * 1991-03-22 1999-06-15 Thomas W. Sander Orthopedic fastener
EP0523926A3 (en) * 1991-07-15 1993-12-01 Smith & Nephew Richards Inc Prosthetic implants with bioabsorbable coating
US5252523A (en) * 1991-10-09 1993-10-12 Corning Incorporated Bioabsorbable chlorophosphate glasses and bioabsorbable glass-polymer blends made therefrom
US5876452A (en) * 1992-02-14 1999-03-02 Board Of Regents, University Of Texas System Biodegradable implant
WO1993017669A1 (en) * 1992-02-28 1993-09-16 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5912015A (en) * 1992-03-12 1999-06-15 Alkermes Controlled Therapeutics, Inc. Modulated release from biocompatible polymers
US5656297A (en) * 1992-03-12 1997-08-12 Alkermes Controlled Therapeutics, Incorporated Modulated release from biocompatible polymers
JPH06105900A (en) * 1992-09-22 1994-04-19 Mitsubishi Materials Corp Bioactive ceramic coated implant
GB9310194D0 (en) * 1993-05-18 1993-06-30 Millenium Bioligix Inc Assessment of osteoclast activity
CA2164859C (en) * 1993-06-10 2005-11-29 Gary Karlin Michelson Apparatus and method of inserting spinal implants
US5442033A (en) * 1993-07-20 1995-08-15 Ethicon, Inc. Liquid copolymers of epsilon-caprolactone and lactide
US5522895A (en) * 1993-07-23 1996-06-04 Rice University Biodegradable bone templates
US5443515A (en) * 1994-01-26 1995-08-22 Implex Corporation Vertebral body prosthetic implant with slidably positionable stabilizing member
CA2551185C (en) 1994-03-28 2007-10-30 Sdgi Holdings, Inc. Apparatus and method for anterior spinal stabilization
US5571189A (en) * 1994-05-20 1996-11-05 Kuslich; Stephen D. Expandable fabric implant for stabilizing the spinal motion segment
US6339130B1 (en) * 1994-07-22 2002-01-15 United States Surgical Corporation Bioabsorbable branched polymers containing units derived from dioxanone and medical/surgical devices manufactured therefrom
US5578662A (en) * 1994-07-22 1996-11-26 United States Surgical Corporation Bioabsorbable branched polymers containing units derived from dioxanone and medical/surgical devices manufactured therefrom
US20020032298A1 (en) * 1994-07-22 2002-03-14 Bennett Steven L. Bioabsorbable branched polymers containing units derived from dioxanone and medical/surgical devices manufactured therefrom
US5769899A (en) * 1994-08-12 1998-06-23 Matrix Biotechnologies, Inc. Cartilage repair unit
US5607686A (en) * 1994-11-22 1997-03-04 United States Surgical Corporation Polymeric composition
AU3795395A (en) 1994-11-30 1996-06-06 Ethicon Inc. Hard tissue bone cements and substitutes
US20030057590A1 (en) * 1994-12-19 2003-03-27 Urs Loher Process for manufacturing components made of fiber-reinforced thermo- plastic materials and components manufactured by this process
US6376573B1 (en) * 1994-12-21 2002-04-23 Interpore International Porous biomaterials and methods for their manufacture
US6758849B1 (en) 1995-02-17 2004-07-06 Sdgi Holdings, Inc. Interbody spinal fusion implants
CN1134810A (en) 1995-02-17 1996-11-06 索发默达纳集团股份有限公司 Improved interbody spinal fusion implants
US5702656A (en) * 1995-06-07 1997-12-30 United States Surgical Corporation Process for making polymeric articles
FI101933B1 (en) * 1995-06-13 1998-09-30 Biocon Oy A joint prosthesis
WO1997007788A2 (en) * 1995-08-31 1997-03-06 Alkermes Controlled Therapeutics, Inc. Composition for sustained release of an agent
US5766253A (en) * 1996-01-16 1998-06-16 Surgical Dynamics, Inc. Spinal fusion device
US5865845A (en) * 1996-03-05 1999-02-02 Thalgott; John S. Prosthetic intervertebral disc
DE69708856D1 (en) * 1996-04-24 2002-01-17 Owens Corning Fiberglass Corp GLASS COMPOSITIONS WITH HIGH AI VALUES AND FIBERS THEREOF
AU2759397A (en) * 1996-05-28 1998-01-05 1218122 Ontario Inc. Resorbable implant biomaterial made of condensed calcium phosphate particles
US5874509A (en) * 1996-07-05 1999-02-23 Clemson University Surface modified glasses and composites thereof
US5964807A (en) 1996-08-08 1999-10-12 Trustees Of The University Of Pennsylvania Compositions and methods for intervertebral disc reformation
US5948000A (en) * 1996-10-03 1999-09-07 United States Surgical Corporation System for suture anchor placement
US5948001A (en) * 1996-10-03 1999-09-07 United States Surgical Corporation System for suture anchor placement
ES2210442T3 (en) * 1996-10-04 2004-07-01 United States Surgical Corporation APPLIANCE FOR THE IMPLEMENTATION OF A FABRIC CLAMP.
CA2217406C (en) * 1996-10-04 2006-05-30 United States Surgical Corporation Suture anchor installation system with disposable loading unit
US5977204A (en) * 1997-04-11 1999-11-02 Osteobiologics, Inc. Biodegradable implant material comprising bioactive ceramic
US6214008B1 (en) * 1997-04-16 2001-04-10 White Spot Ag Biodegradable osteosynthesis implant
US7524335B2 (en) * 1997-05-30 2009-04-28 Smith & Nephew, Inc. Fiber-reinforced, porous, biodegradable implant device
US6113640A (en) * 1997-06-11 2000-09-05 Bionx Implants Oy Reconstructive bioabsorbable joint prosthesis
US6692499B2 (en) 1997-07-02 2004-02-17 Linvatec Biomaterials Oy Surgical fastener for tissue treatment
US6034014A (en) * 1997-08-04 2000-03-07 Owens Corning Fiberglas Technology, Inc. Glass fiber composition
US6241771B1 (en) 1997-08-13 2001-06-05 Cambridge Scientific, Inc. Resorbable interbody spinal fusion devices
GB9717433D0 (en) * 1997-08-19 1997-10-22 Univ Nottingham Biodegradable composites
US6001100A (en) 1997-08-19 1999-12-14 Bionx Implants Oy Bone block fixation implant
ATE234049T1 (en) * 1997-10-31 2003-03-15 Dcs Forschungs & Entwicklungs METHOD AND DEVICE FOR PRODUCING A DENTAL PROSTITUTION PART
US6015410A (en) 1997-12-23 2000-01-18 Bionx Implants Oy Bioabsorbable surgical implants for endoscopic soft tissue suspension procedure
JPH11206871A (en) * 1998-01-27 1999-08-03 Bmg:Kk In vivo degradable and absorptive bone fixing material and its manufacture
US6482233B1 (en) 1998-01-29 2002-11-19 Synthes(U.S.A.) Prosthetic interbody spacer
US5984966A (en) * 1998-03-02 1999-11-16 Bionx Implants Oy Bioabsorbable bone block fixation implant
US6221075B1 (en) 1998-03-06 2001-04-24 Bionx Implants Oy Bioabsorbable, deformable fixation plate
WO1999049792A1 (en) 1998-04-01 1999-10-07 Bionx Implants Oy Bioabsorbable surgical fastener for tissue treatment
US6406498B1 (en) * 1998-09-04 2002-06-18 Bionx Implants Oy Bioactive, bioabsorbable surgical composite material
JP3418350B2 (en) * 1998-09-14 2003-06-23 タキロン株式会社 Biodegradable and absorbable implant material and its shape adjusting method
GB9902976D0 (en) * 1999-02-11 1999-03-31 Giltech Ltd Composite
US6206883B1 (en) 1999-03-05 2001-03-27 Stryker Technologies Corporation Bioabsorbable materials and medical devices made therefrom
US6667049B2 (en) 1999-06-14 2003-12-23 Ethicon, Inc. Relic process for producing bioresorbable ceramic tissue scaffolds
US6451059B1 (en) 1999-11-12 2002-09-17 Ethicon, Inc. Viscous suspension spinning process for producing resorbable ceramic fibers and scaffolds
US6740093B2 (en) * 2000-02-28 2004-05-25 Stephen Hochschuler Method and apparatus for treating a vertebral body
US6723334B1 (en) * 2000-03-01 2004-04-20 Iowa State University Research Foundation, Inc. Biologically compatible bone cements and orthopedic methods
WO2001080751A1 (en) 2000-04-26 2001-11-01 Anchor Medical Technologies, Inc. Bone fixation system
AU2001273632A1 (en) * 2000-06-23 2002-01-08 Drexel University Polymeric, fiber matrix delivery systems for bioactive compounds
US20080086133A1 (en) * 2003-05-16 2008-04-10 Spineology Expandable porous mesh bag device and methods of use for reduction, filling, fixation and supporting of bone
US20020068974A1 (en) * 2000-07-21 2002-06-06 Kuslich Stephen D. Expandable porous mesh bag device and methods of use for reduction, filling, fixation and supporting of bone
US7226480B2 (en) * 2000-08-15 2007-06-05 Depuy Spine, Inc. Disc prosthesis
US6458159B1 (en) * 2000-08-15 2002-10-01 John S. Thalgott Disc prosthesis
US7037324B2 (en) 2000-09-15 2006-05-02 United States Surgical Corporation Knotless tissue anchor
DE10055465A1 (en) * 2000-11-09 2002-05-23 Blz Gmbh Material useful for making bone replacement implants comprises nonmetallic inorganic filler particles embedded in a laser-sinterable biocompatible polymer matrix
US7192604B2 (en) * 2000-12-22 2007-03-20 Ethicon, Inc. Implantable biodegradable devices for musculoskeletal repair or regeneration
JP2004531292A (en) * 2001-01-02 2004-10-14 アドヴァンスト セラミックス リサーチ インコーポレイテッド Biomedically applied compositions and methods
GB2370777B (en) * 2001-01-06 2002-12-31 Roozbeh Shirandami Biodegradable tissue scafold and bone template
US7709029B2 (en) * 2001-01-24 2010-05-04 Ada Foundation Calcium-containing restoration materials
US7294187B2 (en) * 2001-01-24 2007-11-13 Ada Foundation Rapid-hardening calcium phosphate cement compositions
US6793725B2 (en) 2001-01-24 2004-09-21 Ada Foundation Premixed calcium phosphate cement pastes
US7005135B2 (en) * 2001-01-30 2006-02-28 Ethicon Inc. Glass scaffolds with controlled resorption rates and methods for making same
US7497874B1 (en) 2001-02-23 2009-03-03 Biomet Manufacturing Corp. Knee joint prosthesis
US20020120340A1 (en) * 2001-02-23 2002-08-29 Metzger Robert G. Knee joint prosthesis
US6511481B2 (en) 2001-03-30 2003-01-28 Triage Medical, Inc. Method and apparatus for fixation of proximal femoral fractures
FI117963B (en) * 2001-04-26 2007-05-15 Eija Marjut Pirhonen Material that replaces bone
KR100383433B1 (en) * 2001-06-29 2003-05-12 주식회사 씨엠리서치 Method for preparing bioabsorbable organic/inorganic composition for bone fixation devices and itself prepared thereby
US6749639B2 (en) 2001-08-27 2004-06-15 Mayo Foundation For Medical Education And Research Coated prosthetic implant
US6747121B2 (en) 2001-09-05 2004-06-08 Synthes (Usa) Poly(L-lactide-co-glycolide) copolymers, methods for making and using same, and devices containing same
US6685706B2 (en) 2001-11-19 2004-02-03 Triage Medical, Inc. Proximal anchors for bone fixation system
US20030220692A1 (en) * 2002-02-09 2003-11-27 Shapiro Irving M. Preparations of nucleus pulposus cells and methods for their generation, identification, and use
US8506647B2 (en) * 2002-02-14 2013-08-13 Boston Scientific Scimed, Inc. System for maintaining body canal patency
US6955716B2 (en) 2002-03-01 2005-10-18 American Dental Association Foundation Self-hardening calcium phosphate materials with high resistance to fracture, controlled strength histories and tailored macropore formation rates
CA2503376C (en) * 2002-10-28 2011-02-08 Tyco Healthcare Group Lp Bioabsorbable adhesive compounds
NZ539779A (en) * 2002-11-05 2009-01-31 Spineology Inc A semi-biological intervertebral disc replacement system created by inserting tissue promoting material into a cavity in the disc
US20050251267A1 (en) * 2004-05-04 2005-11-10 John Winterbottom Cell permeable structural implant
US20040138683A1 (en) 2003-01-09 2004-07-15 Walter Shelton Suture arrow device and method of using
FI120333B (en) * 2003-08-20 2009-09-30 Bioretec Oy A porous medical device and a method of making it
US8016865B2 (en) * 2003-09-29 2011-09-13 Depuy Mitek, Inc. Method of performing anterior cruciate ligament reconstruction using biodegradable interference screw
GB2407576A (en) * 2003-10-30 2005-05-04 Spinox Ltd Fibres embedded in a glassy protein matrix
US20050107867A1 (en) * 2003-11-17 2005-05-19 Taheri Syde A. Temporary absorbable venous occlusive stent and superficial vein treatment method
SE526985C2 (en) * 2003-11-27 2005-11-29 Doxa Ab Fixation system for implant elements
US8012210B2 (en) * 2004-01-16 2011-09-06 Warsaw Orthopedic, Inc. Implant frames for use with settable materials and related methods of use
US7854756B2 (en) * 2004-01-22 2010-12-21 Boston Scientific Scimed, Inc. Medical devices
US20060015184A1 (en) * 2004-01-30 2006-01-19 John Winterbottom Stacking implants for spinal fusion
WO2005077039A2 (en) * 2004-02-05 2005-08-25 Osteobiologics, Inc. Absorbable orthopedic implants
US7608092B1 (en) 2004-02-20 2009-10-27 Biomet Sports Medicince, LLC Method and apparatus for performing meniscus repair
US20050255779A1 (en) * 2004-04-22 2005-11-17 Ngk Spark Plug Co., Ltd. Organic-inorganic composite porous material, method for producing fibrous organic material, and method for producing organic-inorganic composite porous material
US7819898B2 (en) 2004-06-09 2010-10-26 Biomet Sports Medicine, Llc Method and apparatus for soft tissue fixation
US7695503B1 (en) 2004-06-09 2010-04-13 Biomet Sports Medicine, Llc Method and apparatus for soft tissue attachment
US8109965B2 (en) 2004-06-09 2012-02-07 Biomet Sports Medicine, LLP Method and apparatus for soft tissue fixation
US7500983B1 (en) 2004-06-09 2009-03-10 Biomet Sports Medicine, Llc Apparatus for soft tissue attachment
WO2006026412A2 (en) * 2004-08-31 2006-03-09 Vnus Medical Technologies, Inc. Apparatus and material composition for permanent occlusion of a hollow anatomical structure
WO2006039129A2 (en) * 2004-09-30 2006-04-13 Cytori Therapeutics, Inc. Methods for making and using composites, polymer scaffolds, and composite scaffolds
US8303604B2 (en) 2004-11-05 2012-11-06 Biomet Sports Medicine, Llc Soft tissue repair device and method
US7905904B2 (en) 2006-02-03 2011-03-15 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US7909851B2 (en) 2006-02-03 2011-03-22 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US7601165B2 (en) 2006-09-29 2009-10-13 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable suture loop
US9801708B2 (en) 2004-11-05 2017-10-31 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US7857830B2 (en) 2006-02-03 2010-12-28 Biomet Sports Medicine, Llc Soft tissue repair and conduit device
US8088130B2 (en) 2006-02-03 2012-01-03 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8128658B2 (en) 2004-11-05 2012-03-06 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to bone
US8137382B2 (en) 2004-11-05 2012-03-20 Biomet Sports Medicine, Llc Method and apparatus for coupling anatomical features
US9017381B2 (en) 2007-04-10 2015-04-28 Biomet Sports Medicine, Llc Adjustable knotless loops
US7749250B2 (en) 2006-02-03 2010-07-06 Biomet Sports Medicine, Llc Soft tissue repair assembly and associated method
US8298262B2 (en) 2006-02-03 2012-10-30 Biomet Sports Medicine, Llc Method for tissue fixation
US8361113B2 (en) 2006-02-03 2013-01-29 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US20060189993A1 (en) 2004-11-09 2006-08-24 Arthrotek, Inc. Soft tissue conduit device
US8118836B2 (en) 2004-11-05 2012-02-21 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US7905903B2 (en) 2006-02-03 2011-03-15 Biomet Sports Medicine, Llc Method for tissue fixation
US8840645B2 (en) 2004-11-05 2014-09-23 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8998949B2 (en) 2004-11-09 2015-04-07 Biomet Sports Medicine, Llc Soft tissue conduit device
WO2006062518A2 (en) 2004-12-08 2006-06-15 Interpore Spine Ltd. Continuous phase composite for musculoskeletal repair
US20070038303A1 (en) * 2006-08-15 2007-02-15 Ebi, L.P. Foot/ankle implant and associated method
US8535357B2 (en) * 2004-12-09 2013-09-17 Biomet Sports Medicine, Llc Continuous phase compositions for ACL repair
TW200635566A (en) * 2005-01-25 2006-10-16 Vnus Med Tech Inc Structures for permanent occlusion of a hollow anatomical structure
US20060207607A1 (en) 2005-02-08 2006-09-21 Mark Hirotsuka System and method for percutaneous palate remodeling
CH698152B1 (en) * 2005-02-23 2009-05-29 Gabriel Dr Caduff Biodegradables osteosynthesis system for use in carrying skeleton portion of the human body as well as manufacturing processes.
WO2006113586A2 (en) * 2005-04-15 2006-10-26 Musculoskeletal Transplant Foundation Vertebral disc repair
US7740794B1 (en) 2005-04-18 2010-06-22 Biomet Sports Medicine, Llc Methods of making a polymer and ceramic composite
FI20055194A (en) * 2005-04-27 2006-10-28 Bioretec Oy Bioabsorbent and bioactive composite material and process for manufacturing composite
ES2688274T3 (en) * 2005-06-30 2018-10-31 Unifrax I Llc Inorganic phosphate coated fiber and methods of preparation and use
US20080221624A1 (en) * 2005-10-17 2008-09-11 Gooch Hubert L Systems and Methods for the Medical Treatment of Structural Tissue
US20070118131A1 (en) * 2005-10-17 2007-05-24 Gooch Hubert L Anchor for Augmentation of Screw Purchase and Improvement of Screw Safety in Pedicle Screw Fixation and Bone Fracture Fixation Systems
US20080221623A1 (en) * 2005-10-17 2008-09-11 Gooch Hubert L Systems and Methods for the Medical Treatment of Structural Tissue
AU2007207429A1 (en) 2006-01-19 2007-07-26 Warsaw Orthopedic, Inc. Injectable and moldable bone substitute materials
AU2007207495A1 (en) * 2006-01-19 2007-07-26 Warsaw Orthopedic, Inc. Porous osteoimplant
US9468433B2 (en) 2006-02-03 2016-10-18 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US8562647B2 (en) 2006-09-29 2013-10-22 Biomet Sports Medicine, Llc Method and apparatus for securing soft tissue to bone
US8801783B2 (en) 2006-09-29 2014-08-12 Biomet Sports Medicine, Llc Prosthetic ligament system for knee joint
US9149267B2 (en) 2006-02-03 2015-10-06 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8968364B2 (en) 2006-02-03 2015-03-03 Biomet Sports Medicine, Llc Method and apparatus for fixation of an ACL graft
US8597327B2 (en) 2006-02-03 2013-12-03 Biomet Manufacturing, Llc Method and apparatus for sternal closure
US8652172B2 (en) 2006-02-03 2014-02-18 Biomet Sports Medicine, Llc Flexible anchors for tissue fixation
US8251998B2 (en) 2006-08-16 2012-08-28 Biomet Sports Medicine, Llc Chondral defect repair
US8574235B2 (en) 2006-02-03 2013-11-05 Biomet Sports Medicine, Llc Method for trochanteric reattachment
US8652171B2 (en) 2006-02-03 2014-02-18 Biomet Sports Medicine, Llc Method and apparatus for soft tissue fixation
US11311287B2 (en) 2006-02-03 2022-04-26 Biomet Sports Medicine, Llc Method for tissue fixation
US11259792B2 (en) 2006-02-03 2022-03-01 Biomet Sports Medicine, Llc Method and apparatus for coupling anatomical features
US9078644B2 (en) 2006-09-29 2015-07-14 Biomet Sports Medicine, Llc Fracture fixation device
US9538998B2 (en) 2006-02-03 2017-01-10 Biomet Sports Medicine, Llc Method and apparatus for fracture fixation
US8771352B2 (en) 2011-05-17 2014-07-08 Biomet Sports Medicine, Llc Method and apparatus for tibial fixation of an ACL graft
US8562645B2 (en) 2006-09-29 2013-10-22 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US7959650B2 (en) 2006-09-29 2011-06-14 Biomet Sports Medicine, Llc Adjustable knotless loops
US10517587B2 (en) 2006-02-03 2019-12-31 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US9271713B2 (en) 2006-02-03 2016-03-01 Biomet Sports Medicine, Llc Method and apparatus for tensioning a suture
US8506597B2 (en) 2011-10-25 2013-08-13 Biomet Sports Medicine, Llc Method and apparatus for interosseous membrane reconstruction
US20100009103A1 (en) * 2006-03-17 2010-01-14 Hi-Lex Corporation Medical material
US7828820B2 (en) 2006-03-21 2010-11-09 Biomet Sports Medicine, Llc Method and apparatuses for securing suture
US9017361B2 (en) * 2006-04-20 2015-04-28 Covidien Lp Occlusive implant and methods for hollow anatomical structure
US9101505B2 (en) * 2006-04-27 2015-08-11 Brs Holdings, Llc Composite stent
US20080027560A1 (en) 2006-06-13 2008-01-31 Aspire Medical, Inc. Glossal engagement system and method
US7934506B2 (en) 2006-06-21 2011-05-03 Koninklijke Philips Electronics N.V. System and method for temporary tongue suspension
WO2008011615A2 (en) 2006-07-20 2008-01-24 Orbusneich Medical, Inc. Bioabsorbable polymeric composition for a medical device
WO2008013763A2 (en) * 2006-07-25 2008-01-31 Musculoskeletal Transplant Foundation Packed demineralized cancellous tissue forms for disc nucleus augmentation, restoration, or replacement and methods of implantation
EP2063808A4 (en) * 2006-09-14 2012-06-13 Spineology Inc Absorbent fabric implant
GB0618787D0 (en) * 2006-09-23 2006-11-01 Univ Nottingham Degradable composite
US8500818B2 (en) 2006-09-29 2013-08-06 Biomet Manufacturing, Llc Knee prosthesis assembly with ligament link
US11259794B2 (en) 2006-09-29 2022-03-01 Biomet Sports Medicine, Llc Method for implanting soft tissue
US8672969B2 (en) 2006-09-29 2014-03-18 Biomet Sports Medicine, Llc Fracture fixation device
US9918826B2 (en) 2006-09-29 2018-03-20 Biomet Sports Medicine, Llc Scaffold for spring ligament repair
CN101631513B (en) 2006-10-20 2013-06-05 奥巴斯尼茨医学公司 Bioabsorbable polymeric composition and medical device
US7959942B2 (en) 2006-10-20 2011-06-14 Orbusneich Medical, Inc. Bioabsorbable medical device with coating
US8163028B2 (en) 2007-01-10 2012-04-24 Biomet Manufacturing Corp. Knee joint prosthesis system and method for implantation
US8562616B2 (en) 2007-10-10 2013-10-22 Biomet Manufacturing, Llc Knee joint prosthesis system and method for implantation
US8187280B2 (en) 2007-10-10 2012-05-29 Biomet Manufacturing Corp. Knee joint prosthesis system and method for implantation
EP2104474B1 (en) 2007-01-10 2012-08-29 Biomet Manufacturing Corp. Knee joint prosthesis system
US8328873B2 (en) 2007-01-10 2012-12-11 Biomet Manufacturing Corp. Knee joint prosthesis system and method for implantation
EP2679672B1 (en) 2007-07-12 2016-11-30 Discgenics Human disc tissue
US8556949B2 (en) 2007-11-14 2013-10-15 DePuy Synthes Products, LLC Hybrid bone fixation element and methods of using the same
US8500947B2 (en) * 2007-11-15 2013-08-06 Covidien Lp Speeding cure rate of bioadhesives
US8663326B2 (en) * 2007-12-13 2014-03-04 Said G. Osman Biologic artificial bone
US20090181068A1 (en) * 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
WO2009121064A2 (en) * 2008-03-28 2009-10-01 Spineology, Inc. Method and device for interspinous process fusion
US8614189B2 (en) * 2008-09-24 2013-12-24 University Of Connecticut Carbon nanotube composite scaffolds for bone tissue engineering
US7805920B2 (en) * 2008-11-13 2010-10-05 The Toro Company Lawn mower having steeply inclined exit tunnel and battery access through rear face of mower cutting deck
US20100249924A1 (en) * 2009-03-27 2010-09-30 Allergan, Inc. Bioerodible matrix for tissue involvement
US8343227B2 (en) 2009-05-28 2013-01-01 Biomet Manufacturing Corp. Knee prosthesis assembly with ligament link
US20100310623A1 (en) * 2009-06-05 2010-12-09 Laurencin Cato T Synergetic functionalized spiral-in-tubular bone scaffolds
US9775721B2 (en) 2009-07-10 2017-10-03 Bio2 Technologies, Inc. Resorbable interbody device
US20110206828A1 (en) * 2009-07-10 2011-08-25 Bio2 Technologies, Inc. Devices and Methods for Tissue Engineering
WO2011005935A2 (en) 2009-07-10 2011-01-13 Bio2 Technologies, Inc. Devices and methods for tissue engineering
ES2606042T3 (en) * 2009-10-29 2017-03-17 Prosidyan, Inc. Dynamic bioactive bone graft material and methods for handling
US8444699B2 (en) * 2010-02-18 2013-05-21 Biomet Manufacturing Corp. Method and apparatus for augmenting bone defects
CA2798957A1 (en) 2010-05-10 2011-11-17 Lakshmi Sreedharan Nair Lactoferrin-based biomaterials for tissue regeneration and drug delivery
FI125678B (en) 2011-08-26 2016-01-15 Bioretec Oy BIOABSORABLE, ORIENTED, DEFORMABLE FIXATION MATERIAL AND DISC
US9357991B2 (en) 2011-11-03 2016-06-07 Biomet Sports Medicine, Llc Method and apparatus for stitching tendons
US9381013B2 (en) 2011-11-10 2016-07-05 Biomet Sports Medicine, Llc Method for coupling soft tissue to a bone
US9357992B2 (en) 2011-11-10 2016-06-07 Biomet Sports Medicine, Llc Method for coupling soft tissue to a bone
US9370350B2 (en) 2011-11-10 2016-06-21 Biomet Sports Medicine, Llc Apparatus for coupling soft tissue to a bone
US9259217B2 (en) 2012-01-03 2016-02-16 Biomet Manufacturing, Llc Suture Button
US9155578B2 (en) 2012-02-28 2015-10-13 DePuy Synthes Products, Inc. Expandable fastener
US9180223B2 (en) 2012-05-10 2015-11-10 The Trustees Of The Stevens Institute Of Technology Biphasic osteochondral scaffold for reconstruction of articular cartilage
US9757119B2 (en) 2013-03-08 2017-09-12 Biomet Sports Medicine, Llc Visual aid for identifying suture limbs arthroscopically
US9918827B2 (en) 2013-03-14 2018-03-20 Biomet Sports Medicine, Llc Scaffold for spring ligament repair
SG11201507500XA (en) 2013-03-15 2015-10-29 Unifrax I Llc Inorganic fiber
CN103271760A (en) * 2013-05-27 2013-09-04 中国科学院化学研究所 High-intensity multi-degradation-resistant-protection degradable internal fracture fixation materials and preparation method thereof
US20150024186A1 (en) * 2013-07-17 2015-01-22 Sabic Global Technologies B.V. Force spun sub-micron fiber and applications
US10119214B2 (en) 2013-07-17 2018-11-06 Sabic Global Technologies B.V. Force spun sub-micron fiber and applications
US10136886B2 (en) 2013-12-20 2018-11-27 Biomet Sports Medicine, Llc Knotless soft tissue devices and techniques
US9615822B2 (en) 2014-05-30 2017-04-11 Biomet Sports Medicine, Llc Insertion tools and method for soft anchor
US9700291B2 (en) 2014-06-03 2017-07-11 Biomet Sports Medicine, Llc Capsule retractor
US10023491B2 (en) 2014-07-16 2018-07-17 Unifrax I Llc Inorganic fiber
ES2744914T3 (en) 2014-07-16 2020-02-26 Unifrax I Llc Inorganic fiber with improved shrinkage and strength
WO2016010579A1 (en) 2014-07-17 2016-01-21 Unifrax I Llc Inorganic fiber with improved shrinkage and strength
US10039543B2 (en) 2014-08-22 2018-08-07 Biomet Sports Medicine, Llc Non-sliding soft anchor
CA2955392C (en) 2014-09-07 2024-01-30 Ossio Ltd. Anisotropic biocomposite material, medical implants comprising same and methods of treatment thereof
WO2016103049A1 (en) 2014-12-26 2016-06-30 Resorbium Ltd Continuous-fiber reinforced biocomposite medical implants
US9955980B2 (en) 2015-02-24 2018-05-01 Biomet Sports Medicine, Llc Anatomic soft tissue repair
US9974534B2 (en) 2015-03-31 2018-05-22 Biomet Sports Medicine, Llc Suture anchor with soft anchor of electrospun fibers
US11331191B2 (en) 2015-08-12 2022-05-17 Howmedica Osteonics Corp. Bioactive soft tissue implant and methods of manufacture and use thereof
CA2938576A1 (en) 2015-08-12 2017-02-12 Howmedica Osteonics Corp. Methods for forming scaffolds
WO2017112710A1 (en) 2015-12-21 2017-06-29 Neograft Technologies, Inc. System for creating a graft device
US9919957B2 (en) 2016-01-19 2018-03-20 Unifrax I Llc Inorganic fiber
EP3426312A4 (en) * 2016-03-07 2019-11-13 Ossio Ltd. Surface treated biocomposite material, medical implants comprising same and methods of treatment thereof
EP4356938A2 (en) 2016-05-02 2024-04-24 Howmedica Osteonics Corp. Bioactive soft tissue implant and methods of manufacture and use thereof
CN106730043B (en) 2016-12-19 2022-09-20 苏州西脉新诚生物科技有限公司 High-strength absorbable fracture internal fixation bone screw
MX2020003641A (en) 2017-10-10 2020-07-29 Unifrax I Llc Crystalline silica free low biopersistence inorganic fiber.
US10882779B2 (en) 2018-05-25 2021-01-05 Unifrax I Llc Inorganic fiber

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2501683C3 (en) * 1975-01-17 1979-11-29 Ernst Leitz Wetzlar Gmbh, 6300 Wetzlar Polymer composite material for prosthetic use and process for its manufacture
NL7704659A (en) * 1976-05-12 1977-11-15 Battelle Institut E V BONE REPLACEMENT, BONE JOINT, OR PROSTHESIS ANCHORING MATERIAL.
US4097935A (en) * 1976-07-21 1978-07-04 Sterling Drug Inc. Hydroxylapatite ceramic
FR2364644B1 (en) * 1976-09-20 1981-02-06 Inst Nat Sante Rech Med NEW BONE PROSTHESIS MATERIAL AND ITS APPLICATION
FR2439003A1 (en) * 1978-10-20 1980-05-16 Anvar NEW OSTEOSYNTHESIS PARTS, THEIR PREPARATION AND THEIR APPLICATION
US4329743A (en) * 1979-04-27 1982-05-18 College Of Medicine And Dentistry Of New Jersey Bio-absorbable composite tissue scaffold
US4411027A (en) * 1979-04-27 1983-10-25 University Of Medicine And Dentistry Of New Jersey Bio-absorbable composite tissue scaffold
FR2460657A1 (en) * 1979-07-12 1981-01-30 Anvar BIODEGRADABLE IMPLANT FOR USE AS A BONE PROSTHESIS PIECE
DE2941369A1 (en) * 1979-10-12 1981-04-23 Robert Bosch Gmbh, 7000 Stuttgart MATERIAL FOR MEDICAL TECHNOLOGY
US4360625A (en) * 1979-12-14 1982-11-23 Monsanto Company Acicular, crystalline calcium metaphosphate
JPS57117621A (en) * 1981-01-10 1982-07-22 Mitsubishi Mining & Cement Co Ltd Inorganic fiber of calcium phosphate and an implant material utilizing its properties
JPS584821A (en) * 1981-07-02 1983-01-12 Mitsubishi Mining & Cement Co Ltd Production of calcium phosphate fiber
JPS5946955A (en) * 1982-09-10 1984-03-16 木暮 山人 Hard tissue replacing composite material having stress releasing function during living body motion
US4612923A (en) * 1983-12-01 1986-09-23 Ethicon, Inc. Glass-filled, absorbable surgical devices

Also Published As

Publication number Publication date
EP0146398A3 (en) 1986-09-24
US4655777A (en) 1987-04-07
EP0146398A2 (en) 1985-06-26
JPS60153868A (en) 1985-08-13

Similar Documents

Publication Publication Date Title
CA1261991A (en) Method of producing biodegradable prosthesis and products therefrom
CA2342894C (en) Bioactive, bioabsorbable surgical composites and devices
US4743257A (en) Material for osteosynthesis devices
JP3633909B2 (en) Composite high-strength implant material
US20030206928A1 (en) Bioactive, bioabsorbable surgical polyethylene glycol and polybutylene terephtalate copolymer composites and devices
Leenslag et al. Resorbable materials of poly (l‐lactide). V. Influence of secondary structure on the mechanical properties and hydrolyzability of poly (l‐lactide) fibers produced by a dry‐spinning method
EP0499204B1 (en) Bioabsorbable medical implants
FI81498B (en) SURGICAL MATERIAL OCH INSTRUMENT.
Agrawal et al. Fabrication and characterization of PLA-PGA orthopedic implants
US5652056A (en) Hydroxyapatite filament
KR100383433B1 (en) Method for preparing bioabsorbable organic/inorganic composition for bone fixation devices and itself prepared thereby
Slivka et al. Fiber‐matrix interface studies on bioabsorbable composite materials for internal fixation of bone fractures. I. Raw material evaluation and measurement of fiber—matrix interfacial adhesion
JP2718428B2 (en) Absorbable material for tissue fixation
EP1045677A1 (en) Bioabsorbable fibers and reinforced composites produced therefrom
EP1980279B1 (en) A medical device
JP3239127B2 (en) Composite high-strength implant material and method for producing the same
WO2013098481A1 (en) Composite containing polymer and additive as well as its use
JP2005066354A (en) Composite osteosynthesis material
Dunn et al. Development of Biodegradable Implants for Use in Maxillofacial Surgery.
Miller et al. in Benjamin S. Kelley
Miller et al. Development of Biodegradable Implants for Use in Maxillofacial Surgery
Vannaladsaysy et al. Tensile deformation behavior of collagen/PCL hybrid scaffolds for ligament tissue engineering
Lewis et al. Development of Biodegradable Implants for Use in Maxillofacial Surgery.

Legal Events

Date Code Title Description
MKEX Expiry